A proposed U.S. outbound investment rule could make direct investment and newco formation out of China “somewhere between hard and impossible” in its current form, RA Capital Management’s Joshua ...
Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results